Marksans Pharma Arm Recalls Ibuprofen Tablets from US

Marksans Pharma’s arm, Time-Cap Laboratories Inc, is withdrawing an unspecified number of Ibuprofen tablets, manufactured in Goa, in multiple strengths from the American market on account of a deviation from good manufacturing norms, according to a USFDA report.

The report said that the tablets/caplets were being recalled due to “complaints of odour related to cGMP deficiencies”. The tablets in the strengths of 200 mg, 400 mg, 600 mg and 800 mg and caplets in the strength 200 mg were manufactured for Time Cap Labs Inc by Marksans Pharma at its Goa facility, it added.

The nationwide, voluntary and ongoing recall by Time-Cap Laboratories, Inc is a Class II recall, the USFDA said. According to the USFDA, a Class II recall is initiated in a situation “in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.”

Ibuprofen is a non-steroidal anti-inflammatory drug used for treating pain.